IL6 and severe acute respiratory syndrome: Current evidence suggests that even though COVID-19 significantly impairs tissue function, much of the tissue injury is mediated by the resultant IL-6-driven cytokine storm that exacerbates pulmonary injury and may further damage other peripheral organs as has been reported for SARS [41–43].